Since the identification of the first human coronavirus in the 1960s, a total of six coronaviruses that are known to affect humans have been identified: 229E, OC43, severe acute respiratory syndrome coronavirus (SARS-CoV), NL63, HKU1, and Middle East respiratory syndrome coronavirus (MERS-CoV). Presently, the human world is affected by a novel version of the coronavirus family known as SARS-CoV-2, which has an extremely high contagion rate. Although the infection fatality rate (IFR) of this rapidly spreading virus is not high (ranging from 0.00% to 1.54% across 51 different locations), the increasing number of infections and deaths has created a worldwide pandemic situation. To provide therapy to severely infected patients, instant therapeutic support is urgently needed and the repurposing of already approved drugs is presently in progress. In this regard, the development of nanoparticles as effective transporters for therapeutic drugs or as alternative medicines is highly encouraged and currently needed. The size range of the viruses is within 60– 140 nm, which is slightly larger than the diameters of nanoparticles, making nanomaterials efficacious tools with antiviral properties. Silver-based nanomaterials (AgNMs) demonstrate antimicrobial and disinfectant effects mostly by generating reactive oxygen species (ROS) and are presently considered as a versatile tool for the treatment of COVID-19 patients. Other metal-based nanoparticles have been primarily reported as delivery agents or surface modifying agents, vaccine adjuvant against coronavirus. The present review summarizes and discusses the possible effectiveness of various surface-modified AgNMs against animal coronaviruses and presents a concept for AgNM-based therapeutic treatment of SARS-CoV-2 in the near future.
The present investigation demonstrates the role of protein conformation in synthesizing nanoparticles (NPs) through biomimetic route. Highly water-soluble and biocompatible CdS and CdSe nanoparticles in bovine serum albumin (BSA) matrix have been synthesized using a simple and controllable method at room temperature. Fourier transform infrared (FTIR) data are used to envisage the binding of the semiconducting particles with amide and OH groups of the protein molecule. Optical absorption and emission spectra confirm that particles formed lie within the size quantization regime. Circular dichroism spectroscopy reveals that BSA adopts different conformations at different pH which in turn controls the particle size. Further, addition of sodium borohydride (NaBH4) in BSA solution results in breakage of disulfide bonds generating increased number of thiolate groups which provide better stabilization and increased passivation of electronic defects on particle surface. In the process, better quality semiconductor NPs with higher quantum yield are produced. Thus, by modulating the protein conformation, the size and quality of the nanoparticles can be controlled.